Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

A. Freedman · SciRah

Researcher profile · Semantic Scholar

A. Freedman

Share profile

A. Freedman — researcher profile on SciRah

h-index: 36
Works: 96
Citations: 7,882

Most-cited papers

Revised Bethesda Guidelines for hereditary nonpolyposis colorectal cancer (Lynch syndrome) and microsatellite instability.
A. Umar, C. Boland, Jonathan P. Terdiman, S. Syngal +19 more
2004Journal of the National Cancer Institute3,233 citations Open access
Semantic Scholar
Risk of Heart Failure in Breast Cancer Patients After Anthracycline and Trastuzumab Treatment: A Retrospective Cohort Study
E. J. Aiello Bowles, R. Wellman, H. Feigelson, A. Onitilo +12 more
2012Journal of the National Cancer Institute569 citations Open access
Semantic Scholar
Estimates of the number of US women who could benefit from tamoxifen for breast cancer chemoprevention.
A. Freedman, B. Graubard, Sowmya R. Rao, W. McCaskill-Stevens +2 more
2003Journal of the National Cancer Institute262 citations Open access
Semantic Scholar
Cancer risk prediction models: a workshop on development, evaluation, and application.
A. Freedman, D. Seminara, M. Gail, P. Hartge +3 more
2005Journal of the National Cancer Institute254 citations Open access
Semantic Scholar
Colorectal cancer risk prediction tool for white men and women without known susceptibility.
A. Freedman, M. Slattery, R. Ballard-Barbash, G. Willis +4 more
2009Journal of Clinical Oncology244 citations Open access
Semantic Scholar
Incidence of colorectal carcinoma in the U.S.
R. Troisi, A. Freedman, S. Devesa
1999Cancer183 citations Open access
Semantic Scholar
Benefit/risk assessment for breast cancer chemoprevention with raloxifene or tamoxifen for women age 50 years or older.
A. Freedman, Bin-Bing Yu, M. Gail, J. Costantino +4 more
2011Journal of Clinical Oncology181 citations Open access
Semantic Scholar
Use of Tamoxifen and Raloxifene for Breast Cancer Chemoprevention in 2010
E. Waters, T. McNeel, Worta McCaskill Stevens, A. Freedman
2012Breast Cancer Research and Treatment165 citations Open access
Semantic Scholar
Hereditary breast/ovarian and colorectal cancer genetics knowledge in a national sample of US physicians
L. Wideroff, S. Vadaparampil, M. H. Greene, S. Taplin +2 more
2005Journal of Medical Genetics162 citations Open access
Semantic Scholar
Use of Next-Generation Sequencing Tests to Guide Cancer Treatment: Results From a Nationally Representative Survey of Oncologists in the United States
A. Freedman, C. Klabunde, Kristine Wiant, L. Enewold +16 more
2018JCO Precision Oncology141 citations Open access
Semantic Scholar
The communication of uncertainty regarding individualized cancer risk estimates: effects and influential factors
P. Han, W. Klein, Thomas C. Lehman, B. Killam +2 more
2010Medical decision making140 citations Open access
Semantic Scholar
Physician use of genetic testing for cancer susceptibility: results of a national survey.
L. Wideroff, A. Freedman, Lorayn Olson, C. Klabunde +4 more
2003Cancer Epidemiology, Biomarkers and Prevention136 citations
Semantic Scholar
Prevalence of tamoxifen use for breast cancer chemoprevention among U.S. women
E. Waters, K. Cronin, B. Graubard, P. Han +1 more
2010Cancer Epidemiology, Biomarkers and Prevention133 citations Open access
Semantic Scholar
Validation of a colorectal cancer risk prediction model among white patients age 50 years and older.
Yikyung Park, A. Freedman, M. Gail, D. Pee +3 more
2009Journal of Clinical Oncology130 citations Open access
Semantic Scholar
Gravid health status, medication use, and risk of neuroblastoma.
A. Michalek, G. Buck, P. Nasca, A. Freedman +2 more
1996American Journal of Epidemiology113 citations
Semantic Scholar
What factors are associated with diagnostic follow-up after abnormal mammograms? Findings from a U.S. National Survey.
K. Yabroff, N. Breen, S. Vernon, H. Meissner +2 more
2004Cancer Epidemiology, Biomarkers and Prevention93 citations Open access
Semantic Scholar
Prevalence and correlates of repeat mammography among women aged 55-79 in the Year 2000 National Health Interview Survey.
W. Rakowski, N. Breen, H. Meissner, B. Rimer +3 more
2004Preventive Medicine89 citations
Semantic Scholar
Awareness of Genetic Testing for Increased Cancer Risk in the Year 2000 National Health Interview Survey
L. Wideroff, Susan Thomas Vadaparampil, N. Breen, R. Croyle +1 more
2004Public Health Genomics88 citations
Semantic Scholar
Laypersons’ Responses to the Communication of Uncertainty Regarding Cancer Risk Estimates
P. Han, W. Klein, Thomas C. Lehman, H. Massett +2 more
2009Medical decision making83 citations Open access
Semantic Scholar
Population prevalence of familial cancer and common hereditary cancer syndromes. The 2005 California Health Interview Survey
M. Scheuner, T. McNeel, A. Freedman
2010Genetics in Medicine74 citations Open access
Semantic Scholar
Prognostic implications of molecular and immunohistochemical profiles of the Rb and p53 cell cycle regulatory pathways in primary non-small cell lung carcinoma.
L. Burke, D. Flieder, D. Guinee, E. Brambilla +14 more
2005Clinical Cancer Research74 citations
Semantic Scholar
Correlates of Unrealistic Risk Beliefs in a Nationally Representative Sample
E. Waters, W. Klein, R. Moser, Mandi Yu +3 more
2010Journal of behavioral medicine70 citations Open access
Semantic Scholar
Expression of the hyaluronan receptor, CD44S, in epithelial ovarian cancer is an independent predictor of survival.
Sanjiv Kayastha, A. Freedman, M. Piver, Jhansi Mukkamalla +2 more
1999Clinical Cancer Research68 citations
Semantic Scholar
Immunochemical versus guaiac occult blood stool tests: results of a community-based screening program.
N. Petrelli, A. Michalek, A. Freedman, M. Baroni +2 more
1994Surgical oncology62 citations
Semantic Scholar
The Genomic Applications in Practice and Prevention Network
Muin J. Khoury, W. Feero, M. Reyes, T. Citrin +13 more
2009Genetics in Medicine61 citations Open access
Semantic Scholar
A 22 Gene-expression Assay, Decipher® (GenomeDx Biosciences) to Predict Five-year Risk of Metastatic Prostate Cancer in Men Treated with Radical Prostatectomy
M. Marrone, A. Potosky, D. Penson, A. Freedman
2015PLOS Currents53 citations Open access
Semantic Scholar
Leveraging epidemiology and clinical studies of cancer outcomes: recommendations and opportunities for translational research.
J. Elena, L. Travis, N. I. Simonds, C. Ambrosone +19 more
2013Journal of the National Cancer Institute53 citations Open access
Semantic Scholar
The impact of changes in hormone therapy on breast cancer incidence in the US population
N. Coombs, K. Cronin, Richard J. K. Taylor, A. Freedman +1 more
2009Cancer Causes and Control52 citations
Semantic Scholar
Population Sciences, Translational Research and the Opportunities and Challenges for Genomics to Reduce the Burden of Cancer in the 21st Century
M. Khoury, S. Clauser, A. Freedman, E. Gillanders +3 more
2011Cancer Epidemiology, Biomarkers and Prevention51 citations Open access
Semantic Scholar
Prognostic significance of p53 and p21(waf1/cip1) immunoreactivity in epithelial cancers of the ovary.
B. Werness, A. Freedman, M. Piver, Maritza Romero-Gutierrez +1 more
1999Gynecologic Oncology49 citations
Semantic Scholar
Oncologist Confidence in Genomic Testing and Implications for Using Multimarker Tumor Panel Tests in Practice
J. D. de Moor, S. Gray, S. Mitchell, C. Klabunde +1 more
2020JCO Precision Oncology46 citations Open access
Semantic Scholar
Cancer Pharmacogenomics and Pharmacoepidemiology: Setting a Research Agenda to Accelerate Translation
A. Freedman, L. Sansbury, W. Figg, A. Potosky +24 more
2010Journal of the National Cancer Institute45 citations Open access
Semantic Scholar
Novel Adverse Events of Bevacizumab in the US FDA Adverse Event Reporting System Database
B. K. Shamloo, Pankdeep Chhabra, A. Freedman, A. Potosky +2 more
2012Drug Safety44 citations
Semantic Scholar
Potential increased risk of cancer from commonly used medications: an umbrella review of meta-analyses.
J. Ioannidis, Y. Zhou, C. Chang, S. Schully +2 more
2014Annals of Oncology42 citations Open access
Semantic Scholar
Pharmacogenomics in oncology care
K. Filipski, Leah E. Mechanic, Rochelle Long, A. Freedman
2014Frontiers in Genetics42 citations Open access
Semantic Scholar
The relation between projected breast cancer risk, perceived cancer risk, and mammography use : Results from the national health interview survey (Original Articles)
C. Gross, G. Filardo, H. Singh, A. Freedman +1 more
200637 citations Open access
Semantic Scholar
Comparative effectiveness research in cancer genomics and precision medicine: current landscape and future prospects.
N. I. Simonds, M. Khoury, S. Schully, K. Armstrong +9 more
2013Journal of the National Cancer Institute36 citations Open access
Semantic Scholar
Genome-Based Prediction of Breast Cancer Risk in the General Population: A Modeling Study Based on Meta-Analyses of Genetic Associations
M. van Zitteren, J. B. van der Net, S. Kundu, A. Freedman +2 more
2011Cancer Epidemiology, Biomarkers and Prevention35 citations Open access
Semantic Scholar
The relation between projected breast cancer risk, perceived cancer risk, and mammography use
C. Gross, G. Filardo, H. Singh, A. Freedman +1 more
2006Journal of general internal medicine35 citations
Semantic Scholar
Building the Evidence Base for Decision-making in Cancer Genomic Medicine Using Comparative Effectiveness Research
K. Goddard, W. Knaus, E. Whitlock, G. Lyman +7 more
2012Genetics in Medicine34 citations Open access
Semantic Scholar
Distribution of Genomic Testing Resources by Oncology Practice and Rurality: A Nationally Representative Study
Brittany Gardner, Michelle Doose, Janeth I. Sanchez, A. Freedman +1 more
2021JCO Precision Oncology29 citations Open access
Semantic Scholar
Are we ready to predict late effects? A systematic review of clinically useful prediction models
T. Salz, S. Baxi, N. Raghunathan, Erin E Onstad +9 more
2015European Journal of Cancer27 citations Open access
Semantic Scholar
Commonly used diabetes and cardiovascular medications and cancer recurrence and cancer-specific mortality: a review of the literature
Jennifer W. Wu, D. Boudreau, Yikyung Park, N. I. Simonds +1 more
2014Expert Opinion on Drug Safety26 citations
Semantic Scholar
Stakeholder Assessment of the Evidence for Cancer Genomic Tests: Insights from Three Case Studies
P. Deverka, S. Schully, Naoko Ishibe, J. Carlson +4 more
2012Genetics in Medicine26 citations Open access
Semantic Scholar
Epidemiologic research of rare cancers: trends, resources, and challenges
L. Gallicchio, Danielle L. Daee, M. Rotunno, Rolando Barajas +11 more
2021Cancer Epidemiology, Biomarkers and Prevention25 citations Open access
Semantic Scholar
Use of Oncotype DX in Women with Node-Positive Breast Cancer
Naoko Ishibe, S. Schully, A. Freedman, S. Ramsey
2011PLOS Currents19 citations Open access
Semantic Scholar
Pacemaker Guidelines) Practice Guidelines (ACC/AHA/NASPE Committee to Update the 1998 American College of Cardiology/American Heart Association Task Force on Pacemakers and Antiarrhythmia Devices: Summary Article : A Report of the ACC/AHA/NASPE 2002 Guideline Update for Implantation of Cardiac
D. Faxon, A. Jacobs, V. Fuster, Sidney C. Smith +13 more
200619 citations
Semantic Scholar
Multi-marker Solid Tumor Panels Using Next-generation Sequencing to Direct Molecularly Targeted Therapies
M. Marrone, K. Filipski, E. Gillanders, S. Schully +1 more
2014PLOS Currents18 citations Open access
Semantic Scholar
Targeted Cancer Screening in Average-Risk Individuals
P. Marcus, A. Freedman, M. Khoury
2015American Journal of Preventive Medicine17 citations Open access
Semantic Scholar
Utilization of bevacizumab in US elderly patients with colorectal cancer receiving chemotherapy
A. Fu, Huei-Ting Tsai, J. Marshall, A. Freedman +1 more
2013Journal of Oncology Pharmacy Practice16 citations Open access
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

R. Ballard-Barbash×7
Invite
R. Ballard-Barbash — researcher profile on SciRah
M. Khoury×7
Invite
M. Khoury — researcher profile on SciRah
S. Schully×7
Invite
S. Schully — researcher profile on SciRah
S. Ramsey×5
Invite
S. Ramsey — researcher profile on SciRah

×5

Invite

M. Gail — researcher profile on SciRah

Invite

A. Potosky — researcher profile on SciRah

Invite

K. Goddard — researcher profile on SciRah

Invite

T. McNeel — researcher profile on SciRah

Invite

K. Filipski — researcher profile on SciRah

N. I. Simonds×4

Invite

N. I. Simonds — researcher profile on SciRah

Invite

W. Klein — researcher profile on SciRah

Invite

B. Graubard — researcher profile on SciRah